Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.
- NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_assertion description "[Encouraged by the promising clinical activity of epidermal growth factor receptor (EGFR) kinase inhibitors in treating glioblastoma in humans, we have sequenced the complete EGFR coding sequence in glioma tumor samples and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.
- NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_assertion evidence source_evidence_literature NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.
- NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_assertion SIO_000772 17177598 NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.
- NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_assertion wasDerivedFrom befree-2016 NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.
- NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_assertion wasGeneratedBy ECO_0000203 NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.
- befree-2016 importedOn "2016-02-19" NP584877.RA-gxQ1-A-VvEgN-UFyWCx-uWAaGQ_e-eqCHuNz13Rpkk130_provenance.